Showing results (1801-1810 of 1,907) with videos related to

Sort By:
Pageof 191
Urologic Oncology|December 22, 2019
PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomyHsin-Chih Yeh, Vitaly Margulis, Nirmish Singla, et al.
Gastroenterology|November 8, 2006
Genetic variation in myosin IXB is associated with ulcerative colitisAdriaan A van Bodegraven, Christine R Curley, Karen A Hunt, et al.
Annales De Pathologie|December 16, 2014
[Renal tumors: The International Society of Urologic Pathology (ISUP) 2012 consensus conference recommendations]Nathalie Rioux-Leclercq, Algaba Ferran, Amin Mahul, et al.
Diagnostic Pathology|May 29, 2020
Clinicopathologic features of infection-related glomerulonephritis with IgA deposits: a French Nationwide studyElodie Miquelestorena-Standley, Charlotte Jaulerry, Marie-Christine Machet, et al.
European Urology|November 12, 2025
Nivolumab in Metastatic Clear-cell Renal Cell Carcinoma: An Integrative Biomarker Analysis from the NIVOREN GETUG-AFU 26 Phase 2 StudyRonan Flippot, Yann-Alexandre Vano, Cécile Dalban, et al.
Nature Genetics|January 7, 2015
High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitisPhilippe Goyette, Gabrielle Boucher, Dermot Mallon, et al.
Scientific Reports|June 15, 2023
Optimized testing strategy for the diagnosis of GAA-FGF14 ataxia/spinocerebellar ataxia 27BCéline Bonnet, David Pellerin, Virginie Roth, et al.
Psychiatry Research. Neuroimaging|February 22, 2023
Conduct problems are associated with accelerated thinning of emotion-related cortical regions in a community-based sample of adolescentsMatthew D Albaugh, James J Hudziak, Philip A Spechler, et al.
Gastroenterology|January 9, 2021
Inflamed Ulcerative Colitis Regions Associated With MRGPRX2-Mediated Mast Cell Degranulation and Cell Activation Modules, Defining a New Therapeutic TargetErnie Chen, Ling-Shiang Chuang, Mamta Giri, et al.
Cancer Research|December 17, 2017
H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular CarcinomaJaya Julie Joshi, Heather Coffey, Erik Corcoran, et al.
Pageof 191